Inhibition of heat-shock protein 90 reduces Ebola virus replication.
Ebola virus (EBOV), a negative-sense RNA virus in the family Filoviridae, is known to cause severe hemorrhagic fever in humans and other primates. Infection with EBOV causes a high mortality rate and currently there is no FDA-licensed vaccine or therapeutic treatment available. Recently, heat-shock protein 90 (Hsp90), a molecular chaperone, was shown to be an important host factor for the replication of several negative-strand viruses. We tested the effect of several different Hsp90 inhibitors including geldanamycin, radicicol, and 17-allylamino-17-demethoxygeldanamycin (17-AAG; a geldanamycin analog) on the replication of Zaire EBOV. Our results showed that inhibition of Hsp90 significantly reduced the replication of EBOV. Classic Hsp90 inhibitors reduced viral replication with an effective concentration at 50% (EC(50)) in the high nanomolar to low micromolar range, while drugs from a new class of Hsp90 inhibitors showed markedly more potent inhibition. These compounds blocked EBOV replication with an EC(50) in the low nanomolar range and showed significant potency in blocking replication in primary human monocytes. These results validated that Hsp90 is an important host factor for the replication of filoviruses and suggest that Hsp90 inhibitors may be therapeutically effective in treating EBOV infection.
Smith
Darci R
DR
U.S. Army Medical Research Institute of Infectious Diseases, Virology Division, Fort Detrick, MD, United States.
McCarthy
Sarah
S
Chrovian
Andrew
A
Olinger
Gene
G
Stossel
Andrea
A
Geisbert
Thomas W
TW
Hensley
Lisa E
LE
Connor
John H
JH
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D016227:Benzoquinones / Q000494:pharmacology; D002522:Chlorocebus aethiops; D029043:Ebolavirus / Q000187:drug effects* / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors*; D054884:Host-Pathogen Interactions; D047029:Lactams, Macrocyclic / Q000494:pharmacology; D018942:Macrolides / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D012367:RNA, Viral / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014709:Vero Cells; D010948:Viral Plaque Assay; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D016227:Benzoquinones; D004791:Enzyme Inhibitors; D018841:HSP90 Heat-Shock Proteins; D047029:Lactams, Macrocyclic; D018942:Macrolides; D012367:RNA, Viral; C112765:tanespimycin; C035359:monorden
Science. 1999 Feb 5;283(5403):802-4
10049125
Virology. 2005 Feb 5;332(1):20-7
15661137
Nucleic Acids Res. 2007;35(18):6124-36
17804463
Virology. 2008 Aug 1;377(2):431-9
18570972
Org Lett. 2004 Nov 25;6(24):4459-62
15548050
Lancet. 1977 Mar 12;1(8011):569-71
65661
J Clin Oncol. 2005 Feb 20;23(6):1078-87
15718306
J Cell Physiol. 2001 Sep;188(3):281-90
11473354
J Pharmacol Exp Ther. 2010 Mar;332(3):849-57
19934398
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1060-4
8577714
J Virol. 2002 Feb;76(3):1379-90
11773412
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2717-22
11226306
Antimicrob Agents Chemother. 2004 Mar;48(3):867-72
14982777
Virology. 2007 May 25;362(1):109-19
17258257
Nat Rev Cancer. 2005 Oct;5(10):761-72
16175177
Exp Biol Med (Maywood). 2003 Feb;228(2):111-33
12563018
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1449-54
9465035
Annu Rev Biochem. 2006;75:271-94
16756493
Bioorg Med Chem Lett. 2008 Jun 15;18(12):3517-21
18511277
Arthritis Rheum. 2008 Dec;58(12):3765-75
19035474
J Med Chem. 2009 Jul 23;52(14):4288-305
19552433
J Virol. 2005 Jun;79(11):6827-37
15890922
J Biol Chem. 2002 Nov 22;277(47):45306-14
12226087
J Biol Chem. 2009 Mar 13;284(11):6841-6
19150985
Bioorg Med Chem. 2009 Mar 15;17(6):2225-35
19017562
J Virol. 2005 Aug;79(16):10740-9
16051866
Clin Cancer Res. 2009 Jan 1;15(1):9-14
19118027
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13931-5
11707594
J Virol. 2004 Dec;78(23):13122-31
15542664
Curr Top Microbiol Immunol. 2004;283:61-119
15298168
Genes Dev. 2007 Jan 15;21(2):195-205
17234885
EMBO J. 1997 Jan 2;16(1):59-68
9009268
Biochem Biophys Res Commun. 2007 Feb 23;353(4):882-8
17196931
J Clin Virol. 2004 May;30(1):94-9
15072761
J Virol. 2003 Jan;77(1):732-8
12477878
Am J Pathol. 2003 Dec;163(6):2347-70
14633608
Nature. 1953 Feb 21;171(4347):344
13036885
J Virol. 2007 Feb;81(3):1339-49
17121807